Item 7.01 Regulation FD Disclosure.
In
Cigna expects to realize
Cigna took steps on
Cigna remains committed to its target of achieving consolidated adjusted income
from operations on a per share basis of
Adjusted income (loss) from operations is defined as shareholders' net income
(loss) excluding the following adjustments: net realized investment results,
amortization of acquired intangible assets and special items. Adjusted income
(loss) from operations is a measure of profitability used by Cigna's management
because it presents the underlying results of operations of Cigna's businesses
and permits analysis of trends in underlying revenue, expenses and shareholders'
net income. This consolidated measure is not determined in accordance with
accounting principles generally accepted in
This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act whether made before or after the date of this report, except as shall be expressly set forth by specific reference in such a filing.
CAUTIONARY STATEMENT FOR PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE
PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This Report and oral statements made with respect to information contained in
this Report, may contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking statements are
based on Cigna's current expectations and projections about future trends,
events and uncertainties. These statements are not historical facts.
Forward-looking statements may include, among others, statements relating to our
projected full year 2021 consolidated adjusted income from operations on a per
share basis, projected debt to capitalization ratio, and expectations regarding
capital deployment included in this Report, as well as statements concerning
future financial or operating performance, including our ability to deliver
affordable, personalized and innovative solutions for our customers and clients,
in light of the challenges presented by the COVID-19 pandemic; future growth,
business strategy, strategic or operational initiatives, including our
organizational efficiency plan; economic, regulatory or competitive
environments, particularly with respect to the pace and extent of change in
these areas; financing or capital deployment plans and amounts available for
future deployment; our prospects for growth in the coming years; strategic
transactions, including the merger ("Merger") with
- 2 -
Forward-looking statements are subject to risks and uncertainties, both known
and unknown, that could cause actual results to differ materially from those
expressed or implied in forward-looking statements. Such risks and uncertainties
include, but are not limited to: our ability to achieve our financial, strategic
and operational plans or initiatives; our ability to predict and manage medical
and pharmacy costs and price effectively; our ability to adapt to changes or
trends in an evolving and rapidly changing industry; our ability to effectively
differentiate our products and services from those of our competitors and
maintain or increase market share; our ability to develop and maintain good
relationships with physicians, hospitals, other health care providers,
producers, consultants and pharmaceutical manufacturers; changes in the pharmacy
provider marketplace or pharmacy networks; changes in drug pricing; the impact
of modifications to our operations and processes; our ability to identify
potential strategic transactions and realize the expected benefits (including
anticipated synergies) of such transactions in full or within the anticipated
time frame, including with respect to the Merger, as well as our ability to
integrate or separate operations, resources and systems; the substantial level
of government regulation over our business and the potential effects of new laws
or regulations or changes in existing laws or regulations; the outcome of
litigation, regulatory audits, investigations, actions or guaranty fund
assessments; uncertainties surrounding participation in government-sponsored
programs such as Medicare; the effectiveness and security of our information
technology and other business systems and those of our key suppliers or other
third parties; the impact of our debt service obligations on the availability of
funds for other business purposes; unfavorable industry, economic or political
conditions, including foreign currency movements; acts of civil unrest, war,
terrorism, natural disasters or pandemics; reinsurance credit risk, the scale
and scope of the COVID-19 pandemic and its potential impact on our business,
operating results, cash flows and financial condition, as well as on our
employees, clients, customers, suppliers and partners and on the
- 3 -
© Edgar Online, source